EURACTIV PR

An easy way of publishing your relevant EU press releases.

Medicines for Europe

Press Releases of this organisation

TITLE ORGANISATION DATE TOPIC
HERA must address outstanding weaknesses in EU pharma framework to be successful Medicines for Europe 16 Sep 2021 Health & Consumers
Orphan and paediatric reform should strive to improve access to medicine for rare disease patients and children Medicines for Europe 30 Jul 2021 Health & Consumers
EU must take the lead to ensure security of supply for medicines Medicines for Europe 16 Jun 2021 Health & Consumers
Open borders that prioritise essential goods key to medicines supply in Europe Medicines for Europe 02 Jun 2021 Health & Consumers
EU Industrial strategy should be key to improving medicines supply chains Medicines for Europe 17 May 2021 Health & Consumers
Off patent medicines essential for a fairer, healthier, and sustainable Europe says President Christoph Stoller Medicines for Europe 30 Apr 2021 Health & Consumers
European patients need improved access to biosimilar medicines Medicines for Europe 22 Apr 2021 Health & Consumers
New report assesses progress on biosimilar medicine policies across Europe Medicines for Europe 30 Mar 2021 Health & Consumers
EU industrial policy can dramatically improve medicines manufacturing resilience and security of supply Medicines for Europe 17 Mar 2021 Health & Consumers
New report reveals need for pricing and reimbursement and procurement reforms to ensure patient access and healthcare sustainability Medicines for Europe 01 Mar 2021 Health & Consumers
Smart policies will encourage more critical medicines manufacturing in Europe Medicines for Europe 26 Feb 2021 Health & Consumers
EU must address barriers to continuous off-patent innovation and grasp opportunity for patients and healthcare Medicines for Europe 23 Feb 2021 Health & Consumers
A new medicines trade and health security agenda for the European Commission Medicines for Europe 19 Feb 2021 Health & Consumers
No further excuse to delay digital regulatory infrastructure for medicines after COVID-19 pandemic Medicines for Europe 19 Feb 2021 Health & Consumers
Smarter use of generic, biosimilar and value added medicines will ensure equitable access to cancer care Medicines for Europe 04 Feb 2021 Health & Consumers
AESGP, EFPIA and Medicines for Europe reflections on the European Medicines Agency, the Heads of Medicines Agencies and the European Commission “Key principles for the use of electronic product information for EU medicines” Medicines for Europe 03 Feb 2021 Health & Consumers
Window of opportunity to enhance EU regulatory systems wide open as EU pharma strategy prioritises stronger EU networks Medicines for Europe 19 Jan 2021 Health & Consumers
EU digital strategy requires investments in the digitalisation of Europe’s medicines regulatory agencies to succeed Medicines for Europe 15 Jan 2021 Health & Consumers
EU pharma strategy success depends on access to generic, biosimilar and value added medicines Medicines for Europe 25 Nov 2020 Health & Consumers
European Health Union – first step to greater EU solidarity in health crisis situations Medicines for Europe 11 Nov 2020 Health & Consumers
Failure to launch: white paper explores the role of inappropriate use of IP in blocking access to generic and biosimilar medicines Medicines for Europe 05 Nov 2020 Health & Consumers
Now or never: pragmatism & ambition needed in EU pharma strategy to deliver on Europe’s medicines manufacturing Medicines for Europe 07 Oct 2020 Health & Consumers
Decisive action on medicines shortages should be included in pharmaceutical and industrial strategies Medicines for Europe 18 Sep 2020 Health & Consumers
COVID-19 a lightning rod for major overhaul of EU pharmaceutical policy Medicines for Europe 09 Jul 2020 Health & Consumers
IQVIA Institute Scorecards show biosimilar medicines offer win for patients, policymakers and healthcare systems across Europe Medicines for Europe 30 Jun 2020 Health & Consumers
EU Pharmaceutical Strategy Roadmap: high time to improve patient access to medicines and to apply the lessons from COVID-19 Medicines for Europe 04 Jun 2020 InfoSociety
EMA clarifies no scientific evidence to deter use of ibuprofen to manage coronavirus symptoms Medicines for Europe 18 Mar 2020 Health & Consumers
Medicines for Europe statement on COVID-19 (‘coronavirus’) Medicines for Europe 13 Mar 2020 Health & Consumers
Protecting health: Active generic and biosimilar policies central to EU pharmaceutical strategy Medicines for Europe 03 Mar 2020 Health & Consumers
The European Medicines Verification System (EMVS) celebrates 1 year of successful operation across Europe Medicines for Europe 07 Feb 2020 Health & Consumers, InfoSociety

Pages